Copyright © 2011 Zhen Gao and Stella E. Tsirka. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. S. Dhib-Jalbut, “Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis,” Neurology, vol. 68, no. 22, supplement 3, pp. S13–S54, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
2. T. Holmoy and A. L. Hestvik, “Multiple sclerosis: immunopathogenesis and controversies in defining the cause,” Current Opinion in Infectious Diseases, vol. 21, no. 3, pp. 271–278, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
3. R. P. Lisak, “Neurodegeneration in multiple sclerosis: defining the problem,” Neurology, vol. 68, no. 22, supplement 3, pp. S5–S12, 2007, discussion S43–S54. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
4. J. M. Fletcher, S. J. Lalor, C. M. Sweeney, N. Tubridy, and K. H. G. Mills, “T cells in multiple sclerosis and experimental autoimmune encephalomyelitis,” Clinical and Experimental Immunology, vol. 162, no. 1, pp. 1–11, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
5. D. Centonze, L. Muzio, S. Rossi et al., “Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis,” Journal of Neuroscience, vol. 29, no. 11, pp. 3442–3452, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
6. J. M. van Noort, P. J. van den Elsen, J. van Horssen, J. J. Geurts, P. van der Valk, and S. Amor, “Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies,” CNS & Neurological Disorders Drug Targets, vol. 10, no. 1, pp. 68–81, 2011.
7. P. M. Matthews, E. Pioro, S. Narayanan et al., “Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy,” Brain, vol. 119, no. 3, pp. 715–722, 1996. View at Publisher · View at Google Scholar · View at Scopus
8. D. Pitt, P. Werner, and C. S. Raine, “Glutamate excitotoxicity in a model of multiple sclerosis,” Nature Medicine, vol. 6, no. 1, pp. 67–70, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
9. M. H. Barnett and J. W. Prineas, “Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion,” Annals of Neurology, vol. 55, no. 4, pp. 458–468, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
10. B. Hemmer, J. J. Archelos, and H. P. Hartung, “New concepts in the immunopathogenesis of multiple sclerosis,” Nature Reviews Neuroscience, vol. 3, no. 4, pp. 291–301, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
11. S. Kuerten and D. N. Angelov, “Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice—a step towards understanding the complexity of multiple sclerosis,” Annals of Anatomy, vol. 190, no. 1, pp. 1–15, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
12. A. Denic, A. J. Johnson, A. J. Bieber, A. E. Warrington, M. Rodriguez, and I. Pirko, “The relevance of animal models in multiple sclerosis research,” Pathophysiology, vol. 18, no. 1, pp. 21–29, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
13. E. M. Chastain, D. S. Duncan, J. M. Rodgers, and S. D. Miller, “The role of antigen presenting cells in multiple sclerosis,” Biochimica et Biophysica Acta, vol. 1812, no. 2, pp. 265–274, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
14. M. K. Matyszak and V. H. Perry, “Delayed-type hypersensitivity lesions in the central nervous system are prevented by inhibitors of matrix metalloproteinases,” Journal of Neuroimmunology, vol. 69, no. 1-2, pp. 141–149, 1996. View at Publisher · View at Google Scholar
15. O. Torkildsen, L. A. Brunborg, K.-M. Myhr, and L. Bo, “The cuprizone model for demyelination,” Acta Neurologica Scandinavica, vol. 117, supplement 188, pp. 72–76, 2008. View at Publisher · View at Google Scholar · View at PubMed
16. W. F. Blakemore and R. J. M. Franklin, “Remyelination in experimental models of toxin-induced demyelination,” Current Topics in Microbiology and Immunology, vol. 318, pp. 193–212, 2008. View at Publisher · View at Google Scholar · View at Scopus
17. L. Steinman and S. S. Zamvil, “How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis,” Annals of Neurology, vol. 60, no. 1, pp. 12–21, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
18. N. Koning, B. M. J. Uitdehaag, I. Huitinga, and R. M. Hoek, “Restoring immune suppression in the multiple sclerosis brain,” Progress in Neurobiology, vol. 89, no. 4, pp. 359–368, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
19. N. Koning, L. Bö, R. M. Hoek, and I. Huitinga, “Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions,” Annals of Neurology, vol. 62, no. 5, pp. 504–514, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
20. R. A. Farrell and G. Giovannoni, “Current and future role of interferon beta in the therapy of multiple sclerosis,” Journal of Interferon and Cytokine Research, vol. 30, no. 10, pp. 715–726, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
21. J. S. Wolinsky, “The use of glatiramer acetate in the treatment of multiple sclerosis,” Advances in Neurology, vol. 98, pp. 273–292, 2006. View at Scopus
22. M. Bhasin, M. Wu, and S. E. Tsirka, “Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis,” BMC Immunology, vol. 8, article 10, 2007. View at Publisher · View at Google Scholar · View at PubMed
23. U. K. Hanisch and H. Kettenmann, “Microglia: active sensor and versatile effector cells in the normal and pathologic brain,” Nature Neuroscience, vol. 10, no. 11, pp. 1387–1394, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
24. F. L. Heppner, M. Greter, D. Marino et al., “Experimental autoimmune encephalomyelitis repressed by microglial paralysis,” Nature Medicine, vol. 11, no. 2, pp. 146–152, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
25. I. Napoli and H. Neumann, “Protective effects of microglia in multiple sclerosis,” Experimental Neurology, vol. 225, no. 1, pp. 24–28, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
26. M. Prinz and A. Mildner, “Microglia in the CNS: immigrants from another world,” Glia, vol. 59, no. 2, pp. 177–187, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
27. N. Stence, M. Waite, and M. E. Dailey, “Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices,” Glia, vol. 33, no. 3, pp. 256–266, 2001. View at Scopus
28. K. A. Kigerl, J. C. Gensel, D. P. Ankeny, J. K. Alexander, D. J. Donnelly, and P. G. Popovich, “Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord,” Journal of Neuroscience, vol. 29, no. 43, pp. 13435–13444, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
29. J. Mikita, N. Dubourdieu-Cassagno, M. S. Deloire et al., “Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration,” Multiple Sclerosis, vol. 17, no. 1, pp. 2–15, 2011. View at Publisher · View at Google Scholar · View at PubMed
30. M. Wu and S. E. Tsirka, “Endothelial NOS-deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis,” Glia, vol. 57, no. 11, pp. 1204–1215, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
31. Z. Zhang, Z. Y. Zhang, J. Schittenhelm, Y. Wu, R. Meyermann, and H. J. Schluesener, “Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains,” Journal of Neuroimmunology, vol. 237, no. 1-2, pp. 73–79, 2011. View at Publisher · View at Google Scholar · View at PubMed
32. C. Marik, P. A. Felts, J. Bauer, H. Lassmann, and K. J. Smith, “Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?” Brain, vol. 130, no. 11, pp. 2800–2815, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
33. A. Defaux, M. G. Zurich, P. Honegger, and F. Monnet-Tschudi, “Minocycline promotes remyelination in aggregating rat brain cell cultures after interferon-gamma plus lipopolysaccharide-induced demyelination,” Neuroscience, vol. 187, pp. 84–92, 2011.
34. S. Rasmussen, J. Imitola, A. Ayuso-Sacido et al., “Reversible neural stem cell niche dysfunction in a model of multiple sclerosis,” Annals of Neurology, vol. 69, no. 5, pp. 878–891, 2011. View at Publisher · View at Google Scholar · View at PubMed
35. O. Butovsky, G. Landa, G. Kunis et al., “Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis,” Journal of Clinical Investigation, vol. 116, no. 4, pp. 905–915, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
36. A. C. Murphy, S. J. Lalor, M. A. Lynch, and K. H. G. Mills, “Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis,” Brain, Behavior, and Immunity, vol. 24, no. 4, pp. 641–651, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
37. I. M. Stromnes, L. M. Cerretti, D. Liggitt, R. A. Harris, and J. M. Goverman, “Differential regulation of central nervous system autoimmunity by T H1 and TH17 cells,” Nature Medicine, vol. 14, no. 3, pp. 337–342, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
38. B. Almolda, B. Gonzalez, and B. Castellano, “Antigen presentation in EAE: role of microglia, macrophages and dendritic cells,” Frontiers in Bioscience, vol. 16, no. 3, pp. 1157–1171, 2011. View at Publisher · View at Google Scholar
39. B. Becher, I. Bechmann, and M. Greter, “Antigen presentation in autoimmunity and CNS inflammation: how T iymphocytes recognize the brain,” Journal of Molecular Medicine, vol. 84, no. 7, pp. 532–543, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
40. R. Gandhi, A. Laroni, and H. L. Weiner, “Role of the innate immune system in the pathogenesis of multiple sclerosis,” Journal of Neuroimmunology, vol. 221, no. 1-2, pp. 7–14, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
41. H. G. Fischer and G. Reichmann, “Brain dendritic cells and macrophages/microglia in central nervous system inflammation,” Journal of Immunology, vol. 166, no. 4, pp. 2717–2726, 2001. View at Scopus
42. A. L. Zozulya, B. D. Clarkson, S. Ortler, Z. Fabry, and H. Wiendl, “The role of dendritic cells in CNS autoimmunity,” Journal of Molecular Medicine, vol. 88, no. 6, pp. 535–544, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
43. G. Raivich and R. Banati, “Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease,” Brain Research Reviews, vol. 46, no. 3, pp. 261–281, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
44. E. A. Boyle and P. L. McGeer, “Cellular immune response in multiple sclerosis plaques,” American Journal of Pathology, vol. 137, no. 3, pp. 575–584, 1990. View at Scopus
45. J. G. Pope, C. L. Vanderlugt, S. M. Rahbe, H. L. Lipton, and S. D. Miller, “Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler's murine encephalomyelitis virus,” Journal of Virology, vol. 72, no. 10, pp. 7762–7771, 1998.
46. D. S. Duncan and S. D. Miller, “CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease,” Plos One, vol. 6, no. 4, Article ID e18548, 2011. View at Publisher · View at Google Scholar · View at PubMed
47. B. Almolda, B. Gonzalez, and B. Castellano, “Activated microglial cells acquire an immature dendritic cell phenotype and may terminate the immune response in an acute model of EAE,” Journal of Neuroimmunology, vol. 223, no. 1-2, pp. 39–54, 2010. View at Publisher · View at Google Scholar · View at PubMed
48. C. Blank, J. Kuball, S. Voelkl et al., “Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro,” International Journal of Cancer, vol. 119, no. 2, pp. 317–327, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
49. R. De Simone, A. Giampaolo, B. Giometto et al., “The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions,” Journal of Neuropathology and Experimental Neurology, vol. 54, no. 2, pp. 175–187, 1995. View at Scopus
50. T. Magnus, B. Schreiner, T. Korn et al., “Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS,” Journal of Neuroscience, vol. 25, no. 10, pp. 2537–2546, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
51. S. Ortler, C. Leder, M. Mittelbronn et al., “B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis,” European Journal of Immunology, vol. 38, no. 6, pp. 1734–1744, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
52. E. J. McMahon, S. L. Bailey, C. V. Castenada, H. Waldner, and S. D. Miller, “Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis,” Nature Medicine, vol. 11, no. 3, pp. 335–339, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
53. M. V. Dhodapkar, R. M. Steinman, J. Krasovsky, C. Munz, and N. Bhardwaj, “Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells,” Journal of Experimental Medicine, vol. 193, no. 2, pp. 233–238, 2001. View at Publisher · View at Google Scholar · View at Scopus
54. M. G. Roncarolo, M. K. Levings, and C. Traversari, “Differentiation of T regulatory cells by immature dendritic cells,” Journal of Experimental Medicine, vol. 193, no. 2, pp. F5–F9, 2001. View at Scopus
55. T. D. Merson, M. D. Binder, and T. J. Kilpatrick, “Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS,” NeuroMolecular Medicine, vol. 12, no. 2, pp. 99–132, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
56. C. A. Colton and D. M. Wilcock, “Assessing activation states in microglia,” CNS and Neurological Disorders, vol. 9, no. 2, pp. 174–191, 2010. View at Scopus
57. S. Ebert, J. Gerber, S. Bader et al., “Dose-dependent activation of microglial cells by Toll-like receptor agonists alone and in combination,” Journal of Neuroimmunology, vol. 159, no. 1-2, pp. 87–96, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
58. J. Bauer, T. Sminia, F. G. Wouterlood, and C. D. Dijkstra, “Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis,” Journal of Neuroscience Research, vol. 38, no. 4, pp. 365–375, 1994. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
59. W. W. Li, A. Setzu, C. Zhao, and R. J. M. Franklin, “Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination,” Journal of Neuroimmunology, vol. 158, no. 1-2, pp. 58–66, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
60. S. Pluchino, L. Muzio, J. Imitola et al., “Persistent inflammation alters the function of the endogenous brain stem cell compartment,” Brain, vol. 131, no. 10, pp. 2564–2578, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
61. O. Butovsky, Y. Ziv, A. Schwartz et al., “Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells,” Molecular and Cellular Neuroscience, vol. 31, no. 1, pp. 149–160, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
62. O. Einstein, D. Karussis, N. Grigoriadis et al., “Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis,” Molecular and Cellular Neuroscience, vol. 24, no. 4, pp. 1074–1082, 2003. View at Publisher · View at Google Scholar · View at Scopus
63. O. Einstein, N. Fainstein, I. Vaknin et al., “Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression,” Annals of Neurology, vol. 61, no. 3, pp. 209–218, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
64. S. Pluchino, A. Quattrini, E. Brambilla et al., “Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis,” Nature, vol. 422, no. 6933, pp. 688–694, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
65. J. Yang, Z. Jiang, D. C. Fitzgerald et al., “Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis,” Journal of Clinical Investigation, vol. 119, no. 12, pp. 3678–3691, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
66. K. S. Carbajal, C. Schaumburg, R. Strieter, J. Kane, and T. E. Lane, “Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 24, pp. 11068–11073, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
67. D. Michel-Monigadon, P. Brachet, I. Neveu, and P. Naveilhan, “Immunoregulatory properties of neural stem cells,” Immunotherapy, vol. 3, supplement 4, pp. 39–41, 2011. View at Publisher · View at Google Scholar · View at PubMed
68. N. Fainstein, I. Vaknin, O. Einstein et al., “Neural precursor cells inhibit multiple inflammatory signals,” Molecular and Cellular Neuroscience, vol. 39, no. 3, pp. 335–341, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
69. J. Das Sarma, B. Ciric, R. Marek et al., “Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis,” Journal of Neuroinflammation, vol. 6, article 14, 2009. View at Publisher · View at Google Scholar · View at PubMed
70. J. K. Olson and S. D. Miller, “Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs,” Journal of Immunology, vol. 173, no. 6, pp. 3916–3924, 2004. View at Scopus
71. E. A. Eugenin, K. Osiecki, L. Lopez, H. Goldstein, T. M. Calderon, and J. W. Berman, “CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS,” Journal of Neuroscience, vol. 26, no. 4, pp. 1098–1106, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
72. M. A. Lee, S. Smith, J. Palace, and P. M. Matthews, “Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging,” Brain, vol. 121, no. 11, pp. 2095–2102, 1998. View at Publisher · View at Google Scholar · View at Scopus
73. P. S. Sorensen, B. Wanscher, C. V. Jensen et al., “Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis,” Neurology, vol. 50, no. 5, pp. 1273–1281, 1998. View at Scopus
74. J. E. Simpson, J. Newcombe, M. L. Cuzner, and M. N. Woodroofe, “Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions,” Journal of Neuroimmunology, vol. 84, no. 2, pp. 238–249, 1998. View at Publisher · View at Google Scholar · View at Scopus
75. B. S. Kim, J. P. Palma, D. Kwon, and A. C. Fuller, “Innate immune response induced by Theiler's murine encephalomyelitis virus infection,” Immunologic Research, vol. 31, no. 1, pp. 1–12, 2005. View at Scopus
76. J. Das, G. Ren, L. Zhang et al., “Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation,” Journal of Experimental Medicine, vol. 206, no. 11, pp. 2407–2416, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
77. H. Zhou, B. M. Lapointe, S. R. Clark, L. Zbytnuik, and P. Kubes, “A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide,” Journal of Immunology, vol. 177, no. 11, pp. 8103–8110, 2006. View at Scopus
78. I. Shaked, Z. Porat, R. Gersner, J. Kipnis, and M. Schwartz, “Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system,” Journal of Neuroimmunology, vol. 146, no. 1-2, pp. 84–93, 2004. View at Publisher · View at Google Scholar · View at Scopus
79. S. Rotshenker, “Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease,” Journal of Molecular Neuroscience, vol. 21, no. 1, pp. 65–72, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
80. M. E. Smith, “Phagocytic properties of microglia in vitro: implications for a role in multiple sclerosis and EAE,” Microscopy Research and Technique, vol. 54, no. 2, pp. 81–94, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
81. S. Rotshenker, “The role of Galectin-3/MAC-2 in the activation of the innate-immune function of phagocytosis in microglia in injury and disease,” Journal of Molecular Neuroscience, vol. 39, no. 1-2, pp. 99–103, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
82. M. Gitik, S. L. Zaltsman, P.-A. Oldenborg, et al., “Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPalpha (signal regulatory protein-alpha) on phagocytes,” Journal of Neuroinflammation, vol. 8, article 24, 2011. View at Publisher · View at Google Scholar · View at PubMed
83. M. E. Smith, K. Van Der Maesen, and F. P. Somera, “Macrophage and microglial responses to cytokines in vitro: phagocytic activity, proteolytic enzyme release, and free radical production,” Journal of Neuroscience Research, vol. 54, no. 1, pp. 68–78, 1998. View at Scopus
84. K. Takahashi, M. Prinz, M. Stagi, O. Chechneva, and H. Neumann, “TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis,” Plos Medicine, vol. 4, no. 4, article e124, 2007. View at Publisher · View at Google Scholar · View at PubMed
85. C. D. Schmid, L. N. Sautkulis, P. E. Danielson et al., “Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia,” Journal of Neurochemistry, vol. 83, no. 6, pp. 1309–1320, 2002. View at Publisher · View at Google Scholar · View at Scopus
86. K. Takahashi, C. D. Rochford, and H. Neumann, “Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2,” Journal of Experimental Medicine, vol. 201, no. 4, pp. 647–657, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
87. L. Piccio, C. Buonsanti, M. Mariani et al., “Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis,” European Journal of Immunology, vol. 37, no. 5, pp. 1290–1301, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus